Pfizer to File With FDA for Emergency Use of Vaccine, Moderna Soon to Follow

Pfizer to File With FDA for Emergency Use of Vaccine, Moderna Soon to Follow
Vials of coronavirus vaccine and a medical syringe are seen in front of a displayed Pfizer logo, on Oct. 31, 2020. Dado Ruvic/Reuters
Tom Ozimek
Updated:

Health and Human Services Secretary Alex Azar said Thursday that Pfizer and its partner BioNTech would file for emergency use authorization of their experimental COVID-19 vaccine on Friday, and that he expects Moderna will soon follow with its candidate.

Pfizer confirmed in a press release that it and BioNTech will on Friday submit an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their vaccine candidate, called BNT162b2, a move that “will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end of December 2020.”
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics